1. Altekruse SF KC, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2007. Bethesda: National Cancer Institute; 2010.
2. Percy CL SM, Linet M, Gloeckler Ries LA, Friedman DL. Lymphomas and the Reticuloendothelial neoplasms, in Ries LAG SM, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds): Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649, 1999.
3. Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131:39–49.
4. Seidemann K, Tiemann M, Lauterbach I, et al. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Munster Group. J Clin Oncol. 2003;21:1782–9.
5. Parkin DM, Stiller CA, Draper GJ, et al. The international incidence of childhood cancer. Int J Cancer. 1988;42:511–20.